Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CircuLite’s micropump closer to EU launch with series C

This article was originally published in Clinica

Executive Summary

CircuLite, a Saddle Brook, New Jersey company developing a micropump to help circulation in severe heart failure patients, has closed its series C financing round with total commitments of $32.5m. The round, which was initiated in early 2009, was led by Forbion Capital Partners. CircuLite’s existing shareholders – Crédit Agricole Private Equity, Foundation Medical Partners, Oxford Bioscience Partners – also participated in the financing, along with several private investors. The proceeds will enable CircuLite to complete the ongoing clinical trial of its Synergy pocket micropump and gain CE marking for European commercialisation, as well as begin IDE (investigational device exemption) studies in the US. According to CircuLite, Synergy is the first implantable system designed to provide partial circulatory support for long-term use by class IIIb and early class IV heart failure patients. The company said it will be introducing a new-generation Synergy, which features enhancements resulting from its ongoing product development efforts.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel